Margo S. Farber

Learn More
Discovering unknown adverse drug reactions (ADRs) in postmarketing surveillance as early as possible is of great importance. The current approach to postmarketing surveillance primarily relies on spontaneous reporting. It is a passive surveillance system and limited by gross underreporting (<10% reporting rate), latency, and inconsistent reporting. We(More)
Discovering unknown adverse drug reactions (ADRs) as early as possible is highly desirable. Current methods largely rely on passive spontaneous reports, which suffer from serious underreporting, latency, and inconsistent reporting. They are not ideal for early identification of ADRs [5]. In this paper, we propose a multi-agent system approach for ADR(More)
  • 1